Abstract 2992: Identification of <i>NOTCH1</i> inactivating mutation as a therapeutic vulnerability to PI3K/mTOR pathway inhibition in head and neck squamous cell carcinoma (HNSCC)
Vaishnavi Sambandam(National Comprehensive Cancer Network), Faye M. Johnson(The University of Texas MD Anderson Cancer Center), Jeffrey N. Myers(The University of Texas MD Anderson Cancer Center), Curtis R. Pickering(The University of Texas MD Anderson Cancer Center), Tuhina Mazumdar(The University of Texas MD Anderson Cancer Center), Mitchell J. Frederick(Baylor College of Medicine), Jing Wang(Wenzhou Medical University), Li Shen(The University of Texas MD Anderson Cancer Center), Pan Tong(The University of Texas MD Anderson Cancer Center)
Cited by 1
Related Papers
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
|Science Translational Medicine|2015|502
Extracapsular spread
|Cancer|2001|330
ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis
|Oncogene|2016|215
Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates
|Nature Communications|2016|159